METHOD, DEVICE AND SYSTEM FOR FILLING PHARMACEUTICAL CONTAINERS
20240150050 ยท 2024-05-09
Inventors
- Nick Broadbent (Vancouver, CA)
- Jeroen Immerzeel (Squamish, CA)
- Christopher Procyshyn (Surrey, CA)
- Ross M. Gold (North Vancouver, CA)
- Steve Sang Joon Park (Toronto, CA)
Cpc classification
B65B55/027
PERFORMING OPERATIONS; TRANSPORTING
B65D51/002
PERFORMING OPERATIONS; TRANSPORTING
B65D1/0246
PERFORMING OPERATIONS; TRANSPORTING
B65B55/04
PERFORMING OPERATIONS; TRANSPORTING
B65B7/2821
PERFORMING OPERATIONS; TRANSPORTING
International classification
B65B7/16
PERFORMING OPERATIONS; TRANSPORTING
B65B55/02
PERFORMING OPERATIONS; TRANSPORTING
B65B3/00
PERFORMING OPERATIONS; TRANSPORTING
B65B7/28
PERFORMING OPERATIONS; TRANSPORTING
Abstract
In one general aspect, a method for filling multiple containers with a pharmaceutical product is disclosed, which comprises decontaminating sealed nested materials in a transfer chamber, removing from the sealed nested materials one or both of a container nest holding the multiple containers and a closure nest holding multiple closures, transferring from the transfer chamber to a controlled environment enclosure the removed nest, aseptically filling the containers with the pharmaceutical product, and closing the containers with the multiple closures. The nests are configured to allow multiple closures and containers to be simultaneously aligned concentrically, and closed simultaneously. Spring-loaded retaining structures on the closure nest allow it to releasably retain multiple closures above the corresponding multiple containers. In some embodiments the spring-loaded features are monolithically integrated with the closure nest. The product may be lyophilized in partially sealed containers while the sealing closures are releasably retained by the closure nest.
Claims
1. A closure nest for releasably retaining a plurality of pharmaceutical container closures wherein each closure comprises a stopper retained within a cylindrical cap having a radially extending exterior holding feature, the closure nest comprising a plurality of closure retaining structures arranged on a planar support structure to spatially correspond with the plurality of pharmaceutical containers in the container nest, wherein each closure retaining structure comprises at least one closure engaging structure disposed annularly about a cylindrical axis of the corresponding closure and arranged for friction-independent suspending of the corresponding closure by the holding feature of the corresponding cap.
2. The closure nest of claim 1, wherein the plurality of closure retaining structures is arranged in a geometric pattern.
3. The closure nest of claim 1, wherein the plurality of closure retaining structures is arranged in a hexagonal close packed pattern.
4. The closure nest of claim 1, wherein each of the at least one closure engaging structures comprises an arm extending substantially orthogonally from the planar support structure, wherein the arm comprises a suspension ledge extending toward the cylindrical axis of the corresponding closure and wherein the suspension ledge is disposed for suspending the closure by the holding feature of the cap.
5. The closure nest of claim 4, wherein the arm of each closure engaging structure is a spring-loaded arm.
6. The closure nest of claim 5, wherein the spring-loaded arm of each closure engaging structure is elastically deformable spring-loaded arm.
7. The closure nest of claim 5, wherein the spring-loaded arm of each closure engaging structure is an elastically flexible spring-loaded arm.
8. The closure nest of claim 5, wherein the spring-loaded arm of each closure engaging structure is polymeric.
9. The closure nest of claim 5, wherein the spring-loaded arm of each closure engaging structure is monolithically integrated with the planar support structure.
10. The closure nest of claim 4, wherein the planar support structure comprises a plurality of openings corresponding to the plurality of closure retaining structures and wherein each opening is centered on the cylindrical axis of the corresponding closure.
11. The closure nest of claim 10, wherein each of the at least one closure engaging structures corresponding to each of the plurality of closure retaining structures is disposed annularly around a corresponding opening to provide an annular arrangement of suspension ledges.
12. The closure nest of claim 11, wherein the opening in the planar support structure has a largest dimension smaller than an inner diameter of the annular arrangement of suspension ledges.
13. The closure nest of claim 4, wherein each of the at least one closure engaging structures comprises a stop structure extending substantially orthogonally from the planar support structure for engaging a portion of the top surface of the closure cap.
14. The closure nest of claim 13, wherein the stop structure of each of the at least one closure engaging structures is monolithically integrated with the planar support structure.
15. The closure nest of claim 13, wherein for each of the plurality of closure retaining structures every closure engaging structure of the closure retaining structure shares with all of the other of the at least one closure engaging structures of the closure retaining structure a single stop structure annularly arranged about the cylindrical axis of the corresponding closure.
16. The closure nest of claim 15, wherein the stop structure comprises a plurality of point contacts.
17. The closure nest of claim 1, wherein each closure retaining structure comprises at least three closure engaging structures disposed annularly about the cylindrical axis of the corresponding closure.
18. The closure nest of claim 17, wherein: at least one of the at least three closure engaging structures comprises a spring-loaded arm extending substantially orthogonally from the planar support structure; and all of the at least three closure engaging structures comprise a suspension ledge extending towards the cylindrical axis of the corresponding closure.
19. The closure nest of claim 1, wherein all portions of each of the plurality of closure retaining structures are disposed to remain out of contact with the stopper of a corresponding closure when the corresponding closure is engaged by the at least one closure engaging structure of each of the plurality of closure retaining structures.
Description
BRIEF DESCRIPTION OF DRAWINGS
[0027] The drawings illustrate generally, by way of example, but not by way of limitation, various embodiments discussed in the present document.
[0028]
[0029]
[0030]
[0031]
[0032]
[0033]
[0034]
[0035]
[0036] Corresponding reference characters indicate corresponding parts throughout the several views. Although the drawings represent embodiments of the present invention, the drawings are not necessarily to scale and certain features may be exaggerated in order to better illustrate and explain the present invention. The exemplifications set out herein illustrate embodiments of the invention, in one or more forms, and such exemplifications are not to be construed as limiting the scope of the invention in any manner.
DETAILED DESCRIPTION OF THE INVENTION
[0037] A method and associated system for filling pharmaceutical containers is described at the hand of the schematic depiction in
[0038] Pharmaceutical containers made from tubular glass are commercially available in a range of different sizes with dimensions according to the DIN/ISO 8362-1 standard. Molded glass vials are commercially available in a range of different sizes with dimensions according to the DIN/ISO 8362-4 standard. Frequently vials are used that have one or more additional custom specifications. In some cases these specifications may deviate from the standards.
[0039] Glass has traditionally been the only choice for container material but problems with glass breakage, delamination, particulates due to glass-on-glass collisions, and stability of some products resulted in development and usage of suitable polymeric materials. One example of such polymeric material is TOPAS? cyclic olefin polymer. Vials made of polymeric materials are commercially available in size ranges and dimensions that typically closely mimic those of glass vials.
[0040] Polymeric materials are significantly less scratch resistant than glass and existing aseptic processing equipment has not been redesigned to mitigate the risks of scratching. Scratched surfaces of containers are a serious concern for the perceived quality of the product, but also severely limits the inspection of the containers for particulates. Such inspection is typically a regulated requirement for good manufacturing practice.
[0041] Processing of vials in nests can be an effective solution to prevent scratching of vials such as typically occurs during singulated handling of vials or during simultaneous handling of rows of vials. Handling of vials in nests avoids all vial-tooling and vial-vial collisions. The nests are particularly well suited for processing of polymeric vials but may be used equally well for processing of glass vials.
[0042] Nests for syringes have been commercially available for some decades, but they are a comparatively new concept for the management of pharmaceutical containers beyond syringes. Suitable container nests 70 are available from Nuova Ompi of Newtown, PA and from Afton Scientific of Charlottesville, VA.
[0043] Containers 90, tub 80, and container nest 70 are shown in more detail in
[0044] Closures 120 for containers 90 may be supplied in similar fashion to containers 90, as shown in
[0045] Tubs 80, 110 may be handled within controlled environment enclosure 20 by articulated arm apparatus 22 disposed within controlled environment enclosure 20. Articulated arm apparatus 22 comprises an end of arm tool 24 configured to hold tubs and nests. Articulated arm apparatus 22 may be, without limitation, a robotic articulated arm. Suitable robotic articulated arms are described in U.S. Patent Application Publication US 2009/0223592 A1 and in WIPO PCT Application Publication Number WO 2013/016248 A1, both wholly incorporated herein by reference.
[0046] In contrast to prior art conveyor belt systems, sealed nested closure packages 92, 122, tubs 80, 110 and nests 70, 100 are gripped and held by end of arm tool 24, which may be capable of gripping or holding. Furthermore, as described in co-pending patent application U52009/0223592 A1, titled Robotic filling systems and methods, articulated arm apparatus 22 allows environment enclosure 20 to be cleanable to a much greater degree than a conveyor belt system. Articulated arm apparatus 22 lends itself to being fully automated and this allows a greater degree of automation of the entire container-filling process within the controlled environment enclosure 20 than what is otherwise attainable under such decontaminated or sterilized conditions as pertain within controlled environment enclosure 20. The use of articulated arm apparatus 22 eliminates some of the difficulties described in the background to this specification. In particular, articulated arm apparatus 22 allows the relevant nest to be held in a single action until processing is completed and the container or closure 90, 120 itself is not held, as all handling operations may be carried out by means of nests 70, 100 or tubs 80, 110.
[0047] As regards method, the sealed nested container or closure package 94, 124 may be opened outside filling system 10. Cover 82, 112 may be highly permeable to the atmosphere and therefore the step of removing sealed tub 80, 110 from its packaging 88, 118 may expose not only sealed tub 80, 110 but also its contents to ambient atmosphere.
[0048] With inner door 26 between transfer chamber 30 and controlled environment enclosure 20 closed, outer door 32 of transfer chamber 30 may be opened. Sealed tub 80, 110 containing nest 70, 100 with containers or closures 90, 120 may then be transferred via outer door 32 of transfer chamber 30 onto shelves 34 of transfer chamber 30. Shelves 34 may be, without limitation, carousel shelves.
[0049] In a next step, sealed tub 80, 110 may be decontaminated inside transfer chamber 30. Suitable decontamination includes, but is not limited to, exposure to hydrogen peroxide gas or ozone. Other suitable means of decontamination may include, without limitation, electron beam irradiation and ultraviolet irradiation. Transfer chamber 30 may be any isolatable and decontaminatable vessel, including without limitation, an autoclave or a radiation based decontaminatable vessel that is configured to be placed in spatial communication with controlled environment enclosure 20. In the present specification, the term transfer chamber is used to describe any such vessel that is decontaminatable and which may be placed in spatial communication with controlled environment enclosure 20. Further examples of vessels suitable for use as transfer chamber 30 are provided below.
[0050] In some cases, it may be advantageous to decontaminate transfer chamber 30 together with controlled environment enclosure 20. When decontaminated simultaneously, the seals on inner door 26 will be decontaminated. In some other cases the seal area of door 26 may be negligible.
[0051] Covers 82, 112 may be highly permeable to gases and decontamination agents. Certain materials can be susceptible to significant sorption of decontamination agents during decontamination of the transfer chamber. Exposure of pre-sterilized materials of tub 80, 110 to decontamination agents can be prevented by use of an impermeable cover instead of cover 82, 112, or by addition of an impermeable layer on top of cover 82, 112. Suitable methods for adding such an impermeable layer includes, without limitation adhesive film and heat seals.
[0052] In another aspect of this invention, transfer chamber 30 may be a vacuum chamber; and may be configured to sterilize the contents of tub 80, 110. Thermal and fast non-thermal sterilization cycles are well known in the art. The fast cycle time of non-thermal sterilization cycles may be particularly advantageous. Such cycles are typically used in hospital settings, for example for sterilization of surgical instruments. Gaseous sterilization agents can be hydrogen peroxide, ozone and combinations thereof.
[0053] Transfer chamber 30 may be equipped with a plasma generator for rapid activation and removal of sterilization agents. The addition of non-thermal sterilizing transfer chamber 30 to controlled environment enclosure 20 is particularly well suited for processing of nested pharmaceutical container materials.
[0054] When tub 80, 110 has been decontaminated, inner door 26 may be opened to place the interior of transfer chamber 30 in communication with the interior of controlled environment enclosure 20 and articulated arm apparatus 22 may be employed to remove the sealed nested materials 88, 118 from transfer chamber 30 into controlled environment enclosure 20 through inner door 26. Since articulated arm apparatus 22 is a decontaminated or sterilized structure, and it is gripping tub 80, 110 in a decontaminated environment, the gripping of tub 80, 110 by articulated arm apparatus 22 is referred to in the present specification as aseptically gripping. By way of contrast, other methods of transfer may not involve gripping or may not be aseptic, requiring controlled environment enclosure 20 to be sterilized or decontaminated after transfer.
[0055] Articulated arm apparatus 22 may be employed to remove one or both of lid 86, 116 and sheet 84, 114 within controlled environment enclosure 20. A suitable method for using articulated arm apparatus 22 to remove lid 86, 116 is described in International Patent Application PCT/US13/39455, published as International Application No. WO/2013/166379 on Jul. 11, 2013, which is hereby incorporated in full. Sheet 84, 114 may alternatively be removed using suitable suction. Articulated arm apparatus 22 may then remove the nests 70, 100 with containers or closures 90, 120 from tubs 80, 110.
[0056] Controlled environment enclosure 20 comprises filling station 60. In one embodiment, shown in
[0057] In one embodiment of the method, shown in
[0058] In another embodiment, shown in
[0059] Filling system 10 comprises stoppering apparatus 40 that may have an interior that may be isolated from the interior of controlled environment enclosure 20. The interior of controlled environment enclosure 20 is in communication with an interior of stoppering apparatus 40 via stoppering system door 42. In the embodiment depicted in
[0060] Container nest shelf 46 and closure nest shelf 48 are disposed within the interior of stoppering apparatus 40. Container nest shelf 46 and closure nest shelf 48 are disposed to allow closures 120 in closure nest 100 to be centered on the openings of containers 90 in container nest 70 when closure nest 100 and container nest 70 are placed on respectively container nest shelf 46 and closure nest shelf 48.
[0061] In one embodiment of the method, shown in
[0062] After container nest 70 with containers 90 and closure nest 100 with closures 120 have been located on their respective shelves 46 and 48 within stoppering apparatus 40, stoppering system door WO12013/166379 is closed. To the extent that some stoppering procedures need to be performed under vacuum conditions or under inert atmosphere, the required vacuum or inert atmosphere may then be established within the interior of stoppering apparatus 40.
[0063] Stoppering apparatus 40 is configured to close all containers simultaneously using, for example, actuated ram 44. For some subsequent operations, such as freeze-drying, the stoppers are required to be only partially inserted and actuated ram 44 may be configured to only partially insert stoppers 140. After insertion of stoppers 140, articulated arm apparatus 22 removes nest 70 with containers 90 from stoppering apparatus 40.
[0064] In another embodiment of articulated arm apparatus 22, it loads nested containers 90 and nested caps 130 with integrated stoppers 140 into stoppering apparatus 40. As described above, apparatus 40 may simultaneously stopper and cap nest 70 of containers 90.
[0065] After completion of the stoppering and capping, articulated arm apparatus 22 moves nested containers 90 back into transfer chamber 30. In other embodiments, articulated arm apparatus 22 may move filled, stoppered, and capped nest 70 with containers 90 to an adjacent controlled environment enclosure (not shown) through a suitable communicating door (not shown). Capped nest 70 with containers 90 may be moved to the adjacent controlled environment enclosure with the containers only partially stoppered or partially closed.
[0066]
[0067] In another aspect, this specification provides a nest for holding closures. We consider first generic closure 120 provided in
[0068] In
[0069] In the prior art these vial caps have been made from aluminum with polymeric flip-off covers. Capping of aluminum caps typically generates considerable amounts of non-viable particles and this has tended to make aluminum caps unacceptable in recent times. Caps made of polymeric material are now commercially available. The polymeric caps are particularly well suited for use with polymeric containers, but may also be used for glass containers.
[0070] The most optimal geometry of containers 90 in a nest 70 follows the mathematical theories of equal sized circle packing, leading typically to hexagonal, triangular, square, elongated triangular; snub square and other related geometrical patterns of container positions in nest 70.
[0071] In this specification, closure nest 100 is presented in which the geometrical arrangement of the closures 120, 120 closely matches the geometrical patterns of container positions in nest 70. In some embodiments, closure nest 100 has exactly the same packaging geometry as container nest 70, with the distribution of closure centers in closure nest 100 lining up within a working tolerance with the distribution of container centers in container nest 70. This allows closure nest 100 to be overlayed on container nest 70, and closures 120, 120 to be applied to containers 90 so that all closures 120, 120 in closure nest 100 may be applied to all corresponding containers 90 in container nest 70 without any substantial movement of either nest 70 or nest 100. Closures 120, 120 may be applied one at a time, one row at a time, or all at substantially the same time.
[0072] In
[0073] In
[0074] Closure engaging structures 105, 105 comprising spring-loaded arms 102, 102 and may be implemented in different ways. One non-limiting example of spring-loaded arm 102, 102 and elastically deflectable portion 109, 109 comprise an elastically flexible arm without any other biasing mechanism. Spring-loaded arm 102, 102 may be a separate structure from closure nest 100 that is fastened to closure nest 100 and may have a separate biasing mechanism. In other embodiments, spring-loaded arm 102, 102 and elastically deflectable portion 109, 109 are an integral part of closure nest 100 and may be manufactured to be monolithically integrated with closure nest 100. One non-limiting way of manufacturing spring-loaded arm 102, 102 as a monolithically integrated part of closure nest 100, is by injection molding of a suitable polymer.
[0075] Closure engaging structure 105, 105 holds cap 130, 130 (see
[0076] The integrity of container 90 and closure 120, 120 is achieved by deforming elastomeric stopper 140, 140 by compressing elastomeric stopper 140, 140 against container 90 and permanently holding it in this compressed state by cap 130, 130. The radial compression of stopper 140, 140 by the interference fit inside of the neck of container 90, as indicated with diameter d 4 in
[0077] It is the vertical compression of the flange part of stopper 140, 140 against the top of container 90, on the area of container 90 indicated with diameters d 4 and d 2 in
[0078] It has already been explained in the forgoing that the radial dimensions of container 90 and its corresponding cap 130 must ideally be equal or nearly equal in order to optimize the planar density of containers in container nest 70 and the planar density of corresponding closures in closure nest 100 of
[0079] Different shapes may be employed for stop structures 104, 104, depending on the particular design of the cap. Stop structures 104, 104 also determine the length of spring-loaded arm 102, 102 and therefore its spring retention and opening force. Spring-loaded arm 102, 102 may be substantially linear and orthogonal to closure nest 100, 100, such as in the illustrated embodiment where there is a perpendicular arrangement. In yet other examples the height of stop structures 104, 104 and spring-loaded arm 102, 102 may be reduced by curling radially. In those cases where steam sterilization is required of the caps 130, 130 in the closure nest 100, 100, the contact area between stop structure 104, 104 and cap 130, 130 may be reduced to a series of point contacts to allow for good accessibility of steam.
[0080] Spring-loaded arm 102, 102 may be sized and shaped such that, when cap 130, 130 is secured on container 90, spring-loaded arm 102, 102 may be automatically pushed out of the way by container 90, thereby releasing cap 130, 130. The close packing of closure retaining structures 103, 103 on closure nest 100, 100 implies that there is limited space for lateral motion of spring-loaded arm 102, 102. For example, in a hexagonal close packed arrangement, each closure retaining structure 103, 103 is surrounded by six nearest neighbor closure retaining structures 103, 103 each requiring space for its spring-loaded arms 102, 102 to open in order to release corresponding cap 130, 130. Each spring-loaded arm 102, 102 is sized and positioned to allow caps 130, 130 on neighboring closure retaining structures 103, 103 to be applied simultaneously to containers 90 correspondingly arranged in container nests 70.
[0081] In one embodiment, caps 130, 130 are each held by at least three annularly arranged spring-loaded arms 102, 102 in order to geometrically restrain each cap in its position. In general, each closure retaining structure on closure nest 100, 100 has a plurality of annularly arranged spring-loaded arms 102, 102. In concept, there may be a single annular spring-loaded arm 102, 102 for each single closure retaining structure 103, 103 arranged to grip around the entire perimeter of cap 130, 130, or alternatively around a majority of the perimeter. The most general embodiment of closure nest 100, 100 therefore has at least one spring-loaded arm 102, 102 for each closure retaining structure 103, 103.
[0082] In operation, a plurality of closures 120, 120 is releasably retained in closure nest 100, 100 through being friction-independent suspended by closure engaging structures 105, 105 being engaged with holding features 138, 138 of closures 120, 120, the closure bottoms being a kind of holding feature. To engage closures 120, 120 in this fashion, closures 120, 120 may be pushed into closure retaining structures 103, 103 during which action spring-loaded arms 102, 102 are elastically displaced by caps 130, 130 of closures 120, 120 until suspension ledges 101, 101 click into position on holding features 138, 138. The closures are then supplied to the filling process in this configuration.
[0083] While the closure engaging structures 105, 105 offer initial frictional resistance via a lateral force when closures are pushed into closure retaining structures 103, 103 as part of the process of populating closure nests with closures, the subsequent retention of the closures is independent of any lateral, friction-inducing force orthogonal to the axial direction of movement of closures into a nested condition. Suspension ledges 101, 101 of spring-loaded arms 102, 102 function as barriers to the downward movement of closures, resulting in the closure in each closure-container combination hanging suspended with the closures retained within closure engaging structures 105, 105.
[0084]
[0085] During the closing of container 90 with closure 120, container 90 and closure 120 are vertically forced together. This may be done to a degree that merely causes the top of container 90 to engage with barbed retention features 134 (See
[0086] In a most general description, this specification provides closure nest 100, 100 for releasably retaining a plurality of closures 120, 120 for pharmaceutical containers, closure nest 100, 100 comprising a plurality of closure retaining structures 103, 103 each comprising at least one closure engaging structure 105, 105. The at least one closure engaging structure comprises spring-loaded arm 102, 102 and stop structure 104, 104. The spring-loaded arm 102, 102 is configured to engage with holding feature 138, 138 on one of the plurality of closures 120, 120 and stop structure 104, 104 is configured to confine the one of the plurality of closures 120, 120 and exert force on the one of the plurality of closures when the closures and the closure nest are pushed together vertically. The closure engaging structures may be arranged in a geometric pattern, which geometric pattern may be a close packed pattern and which may match center-to-center a corresponding pattern of container-holding structures in a container nest. Spring-loaded arm 102, 102 may be a flexible structure and may be manufactured from a polymer. Spring-loaded arm 102, 102 may be monolithically integrated with closure nest 100, 100.
[0087] Associated with closure nest 100, 100, a method for holding a plurality of closures 120, 120 comprises releasably retaining each closure 120, 120 by releasably suspending each closure 120, 120 by holding feature 138, 138 on closure 120, 120, the holding feature being a specifically designed holding feature 138, 138 or the bottom of a closure as in
[0088] The method provided here for aseptically sealing a pharmaceutical product into a plurality of containers comprises: introducing a first plurality of containers into a controlled environment enclosure; releasably suspending from a closure nest in the controlled environment a plurality of aseptic closures; filling at least a first portion of the first plurality of containers with the pharmaceutical product; and simultaneously sealing at least partially a second portion of the first plurality of containers with a portion of the plurality of aseptic closures while releasably retaining the aseptic closures in the closure nest. The method may further comprise lyophilizing the pharmaceutical product in the second portion of the first plurality of containers while releasably retaining the aseptic closures in the closure nest.
[0089] The releasably suspending may be friction-independent suspending.
[0090] The releasably suspending and releasably retaining may comprise releasably engaging with a holding feature of each of the plurality of aseptic closures. The releasably engaging with the holding feature may comprise elastically engaging with the holding feature. The elastically engaging with the holding feature may comprise engaging the holding feature with a spring-loaded arm portion of the closure nest.
[0091] Some or all of the plurality of the aseptic closures retained by the closure nest may be used to either fully or partially seal the pharmaceutical product into the containers. The plurality of containers may be equal in number to the number of aseptic closures releasably suspended by the closure nest. Two or more containers may be filled simultaneously.
[0092] As regards benefits, closure nest 100, 100, with its spring-loaded arm 102, 102 and stop structures 104, 104 described in this specification, lends itself to the simultaneous capping and stoppering, both partially and completely, of pluralities of containers 90. More specifically, it lends itself to the simultaneous capping, both partially and completely, of rows of containers 90. Yet more specifically, it lends itself to the simultaneous capping, both partially and completely, of complete two-dimensional arrays of containers 90 in container nests 70. There is no direct contact between closure nest 100, 100 and any parts that will contact the pharmaceutical product. All handling of closures 120, 120 by the articulated arm apparatus 22 is by means of closure nest 100, 100. All contact with the closure nest 100, 100 within the aseptic environment of controlled environment enclosure 20 is by means of devices and surfaces that may be sterilized. As is evident from
[0093] The drawings and the associated descriptions are provided to illustrate embodiments of the invention and not to limit the scope of the invention. Reference in the specification to one embodiment or an embodiment is intended to indicate that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least an embodiment of the invention. The appearances of the phrase in one embodiment or an embodiment in various places in the specification are not necessarily all referring to the same embodiment. As used in this disclosure, except where the context requires otherwise, the term comprise and variations of the term, such as comprising, comprises and comprised are not intended to exclude other additives, components, integers or steps.
[0094] Also, it is noted that the embodiments are disclosed as a process that is depicted as a flowchart, a flow diagram, a structure diagram, or a block diagram. Although a flowchart may disclose various steps of the operations as a sequential process, many of the operations can be performed in parallel or concurrently. The steps shown are not intended to be limiting nor are they intended to indicate that each step depicted is essential to the method, but instead are exemplary steps only. In the foregoing specification, the invention has been described with reference to specific embodiments thereof. It will, however, be evident that various modifications and changes may be made thereto without departing from the broader spirit and scope of the invention. The specification and drawing are, accordingly, to be regarded in an illustrative rather than a restrictive sense. It should be appreciated that the present invention should not be construed as limited by such embodiments.
[0095] From the foregoing description it will be apparent that the present invention has a number of advantages, some of which have been described herein, and others of which are inherent in the embodiments of the invention described or claimed herein. Also, it will be understood that modifications can be made to the device, apparatus and method described herein without departing from the teachings of subject matter described herein. As such, the invention is not to be limited to the described embodiments except as required by the appended claims.